Drug profile · INN
osilodrostat
ISTURISA
osilodrostat (ISTURISA) is a cytochrome p450 11b1 inhibitor. Associated with Recordati Rare Diseases Australia Pty..
EMA: approved TGA: approved Systemic hormonal preparations (H02) H02CA02
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — osilodrostat
- Class
- Systemic hormonal preparations (H02)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
osilodrostat (ISTURISA) is a cytochrome p450 11b1 inhibitor. Associated with Recordati Rare Diseases Australia Pty..
Key facts
INN osilodrostat
Brand ISTURISA
Mechanism Cytochrome P450 11B1 inhibitor
Therapeutic class Systemic hormonal preparations (H02)
ATC code H02CA02
Originator Recordati Rare Diseases Australia Pty.
Mechanism of action
Cytochrome P450 11B1 inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is osilodrostat?
osilodrostat (ISTURISA) is a cytochrome p450 11b1 inhibitor. Associated with Recordati Rare Diseases Australia Pty..
What is the brand name for osilodrostat?
ISTURISA is a marketed brand name for osilodrostat. Check FDA Drugs@FDA for the current US label holder and prescribing information.